Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Foreign Inspection Program "Will Be The Next Area Of Reform" - Mikulski

Executive Summary

FDA's foreign inspection program will be the next agency function to undergo reform, Sen. Mikulski (D-Md.) predicted in an address to PhRMA May 11.

You may also be interested in...



FDA Losing Ground On Foreign Manufacturing Inspections, House Panel Says

Congress is refocusing its interest on an FDA issue that it has looked at periodically for more than a decade: drug import safety and the agency's failure to modernize its foreign inspections program

FDA Losing Ground On Foreign Manufacturing Inspections, House Panel Says

Congress is refocusing its interest on an FDA issue that it has looked at periodically for more than a decade: drug import safety and the agency's failure to modernize its foreign inspections program

FDA IT Infrastructure Inadequate For Managing Foreign Inspections, GAO Says

FDA's ability to oversee drug importation is encumbered by an inaccurate and dysfunctional information technology infrastructure, the Government Accountability Office asserts

Latest News
See All
UsernamePublicRestriction

Register

PS032179

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel